GAO report finds that Gilead Science's remdesivir medicine for severe covid symptoms, which costs over $3k for a five day treatment, was developed by $162 million in research funds provided by the U.S. governmenthttps://www.gao.gov/products/gao-21-272 …
Replying to @lhfang
For ebola, a disease it ended up not helping much. Also it doesn't help much with covid, especially not if you wait until the patient has severe symptoms.
10:53 PM - 1 Apr 2021
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.